Abeona Therapeutics (ABEO)
Commercializes ZEVASKYN for RDEB wounds through qualified treatment centers.
$5.58
vs last close−0.24 (−4.18%)
Something off on this page? Send us feedback.
Next report
Nov 11, 26
in 49 days
EPS estimate
−$0.14
Revenue estimate
$16.5M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.24−$0.24$1.71−$0.10−$0.34−$0.30−$0.35Pending
Estimate−$0.35−$0.35−$0.39−$0.27−$0.35−$0.33−$0.23−$0.14
Surprise+31.0%+31.4%+538.5%+63.0%+2.9%+9.1%−51.1%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported——$400.0K—$5.4M$8.7M$11.4MPending
Estimate$100.0K—$6.5M$5.2M$4.4M$4.6M$12.2M$16.5M
Surprise——−93.9%—+22.0%+90.7%−7.0%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | $0.07 | — | — |
| Sep 2027 | $0.02 | — | — |
| Jun 2027 | −$0.02 | — | — |
| Mar 2027 | −$0.07 | — | — |
| Dec 2026 | −$0.10 | — | — |
| Nov 2026 | −$0.14 | — | — |
| Aug 2026 | −$0.23 | −$0.35 | −51.1% |
| May 2026 | −$0.33 | −$0.30 | +9.1% |
| Mar 2026 | −$0.35 | −$0.34 | +2.9% |
| Nov 2025 | −$0.27 | −$0.10 | +63.0% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Jul 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | $0.07 | — | — | $34.1M | — | — | — |
| Sep 2027 | $0.02 | — | — | $32.0M | — | — | — |
| Jun 2027 | −$0.02 | — | — | $27.4M | — | — | — |
| Mar 2027 | −$0.07 | — | — | $23.3M | — | — | — |
| Dec 2026 | −$0.10 | — | — | $19.2M | — | — | — |
| Nov 11, 2026 | −$0.14 | — | — | $16.5M | — | — | — |
| Aug 13, 2026 | −$0.23 | −$0.35 | −51.1% | $12.2M | $11.4M | −7.0% | −14.9% |
| May 13, 2026 | −$0.33 | −$0.30 | +9.1% | $4.6M | $8.7M | +90.7% | +0.5% |
| Mar 17, 2026 | −$0.35 | −$0.34 | +2.9% | $4.4M | $5.4M | +22.0% | −3.8% |
| Nov 12, 2025 | −$0.27 | −$0.10 | +63.0% | $5.2M | — | — | +18.5% |
| Aug 11, 2025 | |||||||
| May 14, 2025 | |||||||
| Mar 20, 2025 | |||||||
| Nov 14, 2024 | |||||||
| Aug 12, 2024 | |||||||
| May 15, 2024 | |||||||
| Mar 18, 2024 | |||||||
| Nov 13, 2023 | |||||||
| Aug 8, 2023 | |||||||
| May 11, 2023 | |||||||
| Mar 29, 2023 | |||||||
| Nov 14, 2022 | |||||||
| Aug 11, 2022 | |||||||
| May 13, 2022 | |||||||
| Mar 31, 2022 | |||||||
| Nov 15, 2021 | |||||||
| Jul 28, 2021 | |||||||
| May 18, 2021 | |||||||
| Mar 24, 2021 | |||||||
| Nov 9, 2020 | |||||||
| Aug 10, 2020 | |||||||
| May 6, 2020 | |||||||
| Mar 16, 2020 | |||||||
| Nov 12, 2019 | |||||||
| Aug 9, 2019 | |||||||
| May 10, 2019 | |||||||
| Mar 18, 2019 | |||||||
| Nov 9, 2018 | |||||||
| Aug 9, 2018 | |||||||
| May 11, 2018 | |||||||
| Mar 16, 2018 | |||||||
| Nov 15, 2017 | |||||||
| Aug 15, 2017 | |||||||
| May 15, 2017 | |||||||
| Mar 31, 2017 | |||||||
| Nov 14, 2016 | |||||||
| Aug 16, 2016 | |||||||
| May 16, 2016 | |||||||
| Mar 30, 2016 | |||||||
| Nov 17, 2015 | |||||||
| Aug 14, 2015 |